Results 111 to 120 of about 48,070 (253)

Inhibiting effect of digoxin against PDAC in vivo.

open access: yes, 2015
(A): The mice tumors’ volume in different groups. After six weeks of treatment, digoxin therapy decreased the tumors’ volume, which was significantly smaller than those in the saline control group ...
Shasha Li (139491)   +13 more
core   +1 more source

Safety of Intra‐Amniotic and Intra‐Fetal Digoxin Administration in Late Second‐Trimester Abortion by Dilation and Evacuation

open access: yesPerspectives on Sexual and Reproductive Health, EarlyView.
ABSTRACT Objective The study's purpose was to determine the safety of two routes and doses of digoxin through assessment of systemic absorption, cardiac rhythm, and coagulation parameters injected as part of second‐trimester dilation and evacuation abortion.
Eleanor A. Drey   +4 more
wiley   +1 more source

Clinical features and successful management of suicidal digoxin toxicity without use of digoxin-specific antibody (Fab) fragments – is it possible?

open access: yes, 2011
A retrospective study of 147 consecutive cases of suicidal digoxin poisoning was undertaken in order to determine the severity and outcome of toxicity without use of digoxin-specific Fab fragments.
Babak Mostafazadeh   +4 more
core   +1 more source

Lack of effect of ezogabine/retigabine on the pharmacokinetics of digoxin in healthy individuals: results from a drug–drug interaction study

open access: yesClinical Pharmacology: Advances and Applications, 2014
Debra J Tompson,1 Christopher S Crean,2 Mauro Buraglio,1 Thangam Arumugham3 1Clinical Pharmacology Modelling and Simulation, GlaxoSmithKline, Stevenage, Hertfordshire, UK; 2Clinical Pharmacology and Pharmacokinetics, Valeant Pharmaceuticals North America,
Tompson DJ   +3 more
doaj  

Doxorubicin‐induced Cardiotoxicity in Dogs: A Narrative Review

open access: yesVeterinary and Comparative Oncology, EarlyView.
ABSTRACT Doxorubicin, an anthracycline widely used in both human and veterinary oncology, is highly effective against a variety of malignancies in dogs, including lymphomas, sarcomas and carcinomas. Despite its efficacy, doxorubicin exposure can be associated with cardiotoxicity, which may present acutely or chronically, potentially leading to severe ...
Supita Sunpongsri   +4 more
wiley   +1 more source

MRM ion chromatogram of digoxin.

open access: yes, 2015
MRM ion chromatogram of digoxin.
Yang Xin (286771), Shuying Liu (69282)
core   +1 more source

Senolytics and exercise: Dual modalities for rejuvenating muscle

open access: yesThe Journal of Physiology, EarlyView.
Abstract figure legend The role of senolytics on the heart and skeletal muscle. Senescent cell burden increases with ageing, disuse and disease. The senolytics dasatinib+quercetin (D+Q), navitoclax and fisetin, as well as exercise, eliminate senescent cells, reducing senescent cell burden and their senescence‐associated secretory phenotype (SASP ...
Zeynep Elif Yesilyurt‐Dirican   +4 more
wiley   +1 more source

DIGOXIN TOXICITY, COMMON COLD AND HYPOTENSION [PDF]

open access: yes
Digoxin is an important cardiac drug that is widely used in clinical practice. The important concern is on the digoxin toxicity. The toxicity might sometimes come in atypical presentation.
BEHERA, GOURHARI
core  

The plasma kinetics of digoxin-specific Fab fragments and digoxin in the rabbit

open access: yes, 1991
The plasma kinetics of total and free digoxin, and digoxin-specific antibody fragments (DSFab) in rabbits which had been given [3H]digoxin one hour before DSFab has been studied over a 5 day period.
M P Timsina, D S Hewick
core   +1 more source

Effect of green tea catechins on the pharmacokinetics of digoxin in humans

open access: yesDrug Design, Development and Therapy, 2018
Tae-Eun Kim,1 Kwang-Hee Shin,2 Jeong-Eun Park,2 Min-Gul Kim,3 Yeo-Min Yun,4 Dong-Hee Choi,5 Kyoung Ja Kwon,5 Jongmin Lee6 1Department of Clinical Pharmacology, Konkuk University Medical Center, Seoul, Republic of Korea; 2Department of Pharmacotherapy ...
Kim TE   +7 more
doaj  

Home - About - Disclaimer - Privacy